Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era
Work
Year: 2024
Type: article
Abstract: Progression of myeloproliferative neoplasms (MPNs) to accelerated or blast phase is associated with poor survival outcomes. Since 2017 there have been several therapies approved for use in acute myelo... more
Source: Blood Advances
Institutions University of Chicago, Beth Israel Deaconess Medical Center, Princess Margaret Cancer Centre, Yale Cancer Center, Dana-Farber Cancer Institute +10 more
Cites: 43
Cited by: 5
Related to: 10
FWCI: 7.889
Citation percentile (by year/subfield): 99.99
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,000